DICLOFENAC POTASSIUM

DICLOFENAC POTASSIUM was reported 10744 times

These side effects are most commonly reported by patients taking DICLOFENAC POTASSIUM:

# Side effect Count
0 DRUG INEFFECTIVE 2826
1 FATIGUE 2577
2 RHEUMATOID ARTHRITIS 2570
3 OFF LABEL USE 2492
4 PAIN 2477
5 RASH 2456
6 SYSTEMIC LUPUS ERYTHEMATOSUS 2403
7 JOINT SWELLING 2366
8 WOUND 2280
9 PEMPHIGUS 2230
10 SYNOVITIS 2211
11 GLOSSODYNIA 2200
12 SWELLING 2184
13 ABDOMINAL DISCOMFORT 2181
14 HAND DEFORMITY 2177
15 INFUSION RELATED REACTION 2175
16 PERICARDITIS 2169
17 HEPATIC ENZYME INCREASED 2138
18 ARTHRALGIA 2115
19 ALOPECIA 2109
20 HEADACHE 2101
21 PSORIATIC ARTHROPATHY 2100
22 TYPE 2 DIABETES MELLITUS 2098
23 HYPERSENSITIVITY 2085
24 HELICOBACTER INFECTION 2082
25 HYPERTENSION 2047
26 DUODENAL ULCER PERFORATION 2026
27 ARTHROPATHY 2009
28 GENERAL PHYSICAL HEALTH DETERIORATION 2007
29 VOMITING 1979
30 HYPOAESTHESIA 1969
31 FIBROMYALGIA 1894
32 DRUG INTOLERANCE 1884
33 IMPAIRED HEALING 1809
34 CONDITION AGGRAVATED 1782
35 BLOOD CHOLESTEROL INCREASED 1772
36 IRRITABLE BOWEL SYNDROME 1771
37 WEIGHT INCREASED 1771
38 NAUSEA 1765
39 BLISTER 1764
40 RHEUMATIC FEVER 1761
41 MOBILITY DECREASED 1759
42 FOLLICULITIS 1758
43 INJURY 1739
44 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1728
45 URTICARIA 1720
46 DISCOMFORT 1719
47 LIVER INJURY 1706
48 MUSCULOSKELETAL STIFFNESS 1705
49 STOMATITIS 1702
50 MATERNAL EXPOSURE DURING PREGNANCY 1685
51 WHEEZING 1653
52 NASOPHARYNGITIS 1646
53 DIARRHOEA 1644
54 DIZZINESS 1631
55 MALAISE 1616
56 DECREASED APPETITE 1615
57 CONFUSIONAL STATE 1591
58 INFECTION 1586
59 TREATMENT FAILURE 1572
60 RHEUMATOID FACTOR POSITIVE 1569
61 LOWER RESPIRATORY TRACT INFECTION 1551
62 PERIPHERAL SWELLING 1543
63 MUSCLE INJURY 1542
64 PRODUCT USE IN UNAPPROVED INDICATION 1541
65 JOINT RANGE OF MOTION DECREASED 1528
66 DYSPNOEA 1496
67 DRUG HYPERSENSITIVITY 1475
68 PYREXIA 1472
69 INTENTIONAL PRODUCT USE ISSUE 1454
70 OSTEOARTHRITIS 1454
71 PRURITUS 1436
72 PRODUCT USE ISSUE 1435
73 DRY MOUTH 1430
74 ABDOMINAL PAIN UPPER 1423
75 CONTRAINDICATED PRODUCT ADMINISTERED 1419
76 SINUSITIS 1398
77 LIP DRY 1386
78 ASTHENIA 1380
79 THERAPEUTIC PRODUCT EFFECT DECREASED 1349
80 SWOLLEN JOINT COUNT INCREASED 1333
81 ILL-DEFINED DISORDER 1294
82 FACET JOINT SYNDROME 1289
83 GASTROINTESTINAL DISORDER 1278
84 CONTUSION 1268
85 INFLAMMATION 1240
86 SLEEP DISORDER 1235
87 BURSITIS 1215
88 ROAD TRAFFIC ACCIDENT 1199
89 OEDEMA 1194
90 MUSCULOSKELETAL PAIN 1178
91 LUNG DISORDER 1177
92 MIGRAINE 1174
93 INSOMNIA 1173
94 C-REACTIVE PROTEIN ABNORMAL 1162
95 MUSCLE SPASMS 1156
96 PAIN IN EXTREMITY 1139
97 NIGHT SWEATS 1129
98 GAIT INABILITY 1126
99 CHEST PAIN 1118
100 PNEUMONIA 1111
101 HYPERCHOLESTEROLAEMIA 1109
102 WOUND INFECTION 1106
103 SCIATICA 1092
104 MEMORY IMPAIRMENT 1088
105 ASTHMA 1082
106 DEPRESSION 1056
107 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1049
108 LIVER DISORDER 1036
109 LOWER LIMB FRACTURE 1034
110 PARAESTHESIA 1022
111 C-REACTIVE PROTEIN INCREASED 1013
112 ANXIETY 1007
113 AUTOIMMUNE DISORDER 990
114 DEEP VEIN THROMBOSIS POSTOPERATIVE 977
115 PRESCRIBED OVERDOSE 966
116 BREAST CANCER STAGE III 962
117 DYSPEPSIA 960
118 OBESITY 951
119 PERIPHERAL VENOUS DISEASE 948
120 GAIT DISTURBANCE 934
121 GRIP STRENGTH DECREASED 930
122 WEIGHT DECREASED 913
123 PULMONARY FIBROSIS 866
124 OEDEMA PERIPHERAL 840
125 EXPOSURE DURING PREGNANCY 838
126 MUSCULAR WEAKNESS 813
127 ADVERSE EVENT 774
128 ABDOMINAL PAIN 764
129 PRESCRIBED UNDERDOSE 763
130 ADVERSE DRUG REACTION 740
131 LIVE BIRTH 711
132 DELIRIUM 706
133 THERAPY NON-RESPONDER 701
134 DISLOCATION OF VERTEBRA 700
135 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 687
136 AMNESIA 679
137 HIP ARTHROPLASTY 640
138 LUPUS VULGARIS 623
139 BONE EROSION 619
140 HEPATIC CIRRHOSIS 602
141 EXOSTOSIS 591
142 KNEE ARTHROPLASTY 590
143 EAR INFECTION 589
144 JOINT STIFFNESS 589
145 LARYNGITIS 584
146 GASTROOESOPHAGEAL REFLUX DISEASE 583
147 EPILEPSY 581
148 LUPUS-LIKE SYNDROME 579
149 CROHN^S DISEASE 576
150 RED BLOOD CELL SEDIMENTATION RATE INCREASED 575
151 RETINITIS 574
152 VISUAL IMPAIRMENT 573
153 OSTEOPOROSIS 541
154 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 538
155 ARTHRITIS 524
156 DRUG-INDUCED LIVER INJURY 512
157 JOINT DISLOCATION 512
158 BLEPHAROSPASM 504
159 X-RAY ABNORMAL 503
160 FOOT DEFORMITY 479
161 C-REACTIVE PROTEIN 474
162 PRODUCT QUALITY ISSUE 473
163 MEDICATION ERROR 467
164 LIVER FUNCTION TEST INCREASED 463
165 TASTE DISORDER 455
166 PSORIASIS 444
167 NAIL DISORDER 423
168 UPPER RESPIRATORY TRACT INFECTION 413
169 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 398
170 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 385
171 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 379
172 PREGNANCY 377
173 UNDERDOSE 352
174 WALKING AID USER 332
175 BREAST CANCER STAGE II 331
176 FALL 329
177 TACHYCARDIA 323
178 RESPIRATORY DISORDER 312
179 ONYCHOMADESIS 311
180 THERAPEUTIC RESPONSE DECREASED 304
181 FEELING HOT 300
182 DISABILITY 297
183 BACK PAIN 296
184 EAR PAIN 294
185 COLITIS ULCERATIVE 289
186 DEATH 287
187 BRONCHITIS 281
188 FREQUENT BOWEL MOVEMENTS 280
189 RECTAL HAEMORRHAGE 274
190 NECK PAIN 273
191 SERONEGATIVE ARTHRITIS 266
192 PORPHYRIA ACUTE 259
193 PANCREATITIS 255
194 INJECTION SITE REACTION 253
195 ONYCHOMYCOSIS 248
196 BACK INJURY 247
197 HOSPITALISATION 245
198 COELIAC DISEASE 232
199 MATERNAL EXPOSURE TIMING UNSPECIFIED 232
200 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 230
201 WHITE BLOOD CELL COUNT INCREASED 227
202 FLUID RETENTION 222
203 DRUG TOLERANCE DECREASED 221
204 ULCER HAEMORRHAGE 221
205 CONGENITAL ANOMALY 216
206 FOETAL EXPOSURE DURING PREGNANCY 211
207 OVERDOSE 206
208 THROMBOCYTOPENIA 190
209 SPONDYLITIS 183
210 ABDOMINAL DISTENSION 182
211 ADVERSE REACTION 180
212 LABORATORY TEST ABNORMAL 175
213 INTENTIONAL PRODUCT MISUSE 173
214 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 170
215 HEPATITIS 158
216 HYPERHIDROSIS 148
217 FINGER DEFORMITY 142
218 MUSCLE SPASTICITY 142
219 PHARYNGITIS 140
220 INFUSION SITE REACTION 135
221 GRIP STRENGTH 134
222 PRODUCT LABEL CONFUSION 134
223 DEATH NEONATAL 124
224 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 124
225 FEELING ABNORMAL 121
226 SPINAL FUSION SURGERY 121
227 CONSTIPATION 120
228 BACK DISORDER 119
229 GASTROINTESTINAL PAIN 110
230 COUGH 109
231 IMMUNODEFICIENCY 109
232 SWOLLEN JOINT COUNT 108
233 SOMNOLENCE 107
234 WEIGHT FLUCTUATION 106
235 ANKYLOSING SPONDYLITIS 102
236 DEAFNESS 102
237 NORMAL NEWBORN 101
238 HYPOCHOLESTEROLAEMIA 99
239 DRUG TOLERANCE 98
240 HYPOPHAGIA 98
241 FEEDING DISORDER 96
242 ERYTHEMA 95
243 DEAFNESS TRANSITORY 93
244 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 92
245 MUSCULOSKELETAL DISORDER 92
246 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 92
247 BLOOD PRESSURE INCREASED 89
248 NEPHROLITHIASIS 89
249 NO ADVERSE EVENT 89
250 FUNCTIONAL GASTROINTESTINAL DISORDER 88
251 LOSS OF CONSCIOUSNESS 88
252 MYOSITIS 88
253 PUSTULAR PSORIASIS 88
254 RASH VESICULAR 87
255 ILLNESS 86
256 PRODUCT DOSE OMISSION ISSUE 86
257 GENERAL SYMPTOM 81
258 MOVEMENT DISORDER 81
259 RASH PRURITIC 80
260 TENDERNESS 79
261 TREATMENT NONCOMPLIANCE 79
262 HEPATIC ENZYME 78
263 DRUG INTERACTION 76
264 HYPOTENSION 76
265 NIGHTMARE 76
266 JOINT DESTRUCTION 74
267 SEDATION 74
268 RASH ERYTHEMATOUS 73
269 URINARY TRACT INFECTION 64
270 COVID-19 61
271 EYE INJURY 61
272 ABNORMAL LOSS OF WEIGHT 59
273 BODY TEMPERATURE INCREASED 59
274 INCORRECT PRODUCT ADMINISTRATION DURATION 58
275 INFLUENZA 58
276 INJECTION SITE PAIN 58
277 SUICIDAL IDEATION 58
278 LEUKOPENIA 56
279 SPINAL STENOSIS 56
280 TREMOR 56
281 ANAPHYLACTIC REACTION 55
282 BURNING SENSATION 55
283 MYALGIA 55
284 PLATELET COUNT INCREASED 55
285 SEIZURE 55
286 TEMPERATURE REGULATION DISORDER 55
287 PAIN IN JAW 54
288 VISION BLURRED 54
289 OROPHARYNGEAL PAIN 53
290 ACUTE KIDNEY INJURY 52
291 FOOD ALLERGY 52
292 FOOT OPERATION 52
293 EYE PAIN 51
294 SHOULDER ARTHROPLASTY 51
295 ADRENAL INSUFFICIENCY 50
296 FOETAL DEATH 48
297 HYPOKALAEMIA 48
298 RESPIRATORY TRACT INFECTION 48
299 CHRONIC KIDNEY DISEASE 47
300 POLYARTHRITIS 44
301 DEEP VEIN THROMBOSIS 43
302 EATING DISORDER 42
303 GASTRIC ULCER 42
304 IMPAIRED WORK ABILITY 42
305 DRY EYE 41
306 RENAL FAILURE 41
307 DRUG PRESCRIBING ERROR 40
308 BREAST CANCER STAGE I 39
309 DISEASE RECURRENCE 39
310 DRUG EFFECT DECREASED 39
311 PRODUCT TASTE ABNORMAL 39
312 DYSPHAGIA 38
313 STAPHYLOCOCCAL INFECTION 38
314 STRESS 38
315 SEPSIS 37
316 SURGERY 37
317 DEHYDRATION 36
318 PRE-EXISTING CONDITION IMPROVED 36
319 SYNCOPE 36
320 THROMBOSIS 36
321 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36
322 CHILLS 35
323 COMPLETED SUICIDE 35
324 DEFORMITY 35
325 JOINT EFFUSION 35
326 PALPITATIONS 35
327 UNEVALUABLE EVENT 34
328 WHITE BLOOD CELL COUNT DECREASED 34
329 ACCIDENTAL OVERDOSE 33
330 CARDIAC DISORDER 33
331 DIABETES MELLITUS 33
332 DISEASE PROGRESSION 33
333 HYPERTRANSAMINASAEMIA 33
334 OVERLAP SYNDROME 33
335 SWELLING FACE 33
336 THERAPEUTIC RESPONSE UNEXPECTED 33
337 BALANCE DISORDER 32
338 PHOTOPHOBIA 32
339 WRIST DEFORMITY 32
340 CEREBROVASCULAR ACCIDENT 31
341 PRODUCTIVE COUGH 31
342 ANAEMIA 30
343 EYE DISORDER 30
344 HERPES ZOSTER 30
345 NEUROPATHY PERIPHERAL 30
346 THROAT IRRITATION 30
347 ASPIRATION 29
348 INCORRECT DOSE ADMINISTERED 29
349 PULMONARY EMBOLISM 29
350 DRUG ERUPTION 28
351 DRY SKIN 28
352 LYME DISEASE 28
353 MEAN CELL HAEMOGLOBIN DECREASED 28
354 MONOCYTE COUNT INCREASED 28
355 MUSCULOSKELETAL DEFORMITY 28
356 RED BLOOD CELL SEDIMENTATION RATE 28
357 RED CELL DISTRIBUTION WIDTH DECREASED 28
358 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 28
359 VASCULAR ACCESS COMPLICATION 28
360 VERTIGO 28
361 CELLULITIS 27
362 HAEMOGLOBIN DECREASED 27
363 HYPONATRAEMIA 27
364 INJECTION SITE ERYTHEMA 27
365 MEAN CELL VOLUME DECREASED 27
366 MEAN PLATELET VOLUME DECREASED 27
367 NASAL CONGESTION 27
368 SLEEP APNOEA SYNDROME 27
369 DYSSTASIA 26
370 EMOTIONAL DISTRESS 26
371 INFLUENZA LIKE ILLNESS 26
372 OXYGEN SATURATION DECREASED 26
373 RENAL IMPAIRMENT 26
374 RHINORRHOEA 26
375 ACCIDENTAL EXPOSURE TO PRODUCT 25
376 CHEST DISCOMFORT 25
377 FLUSHING 25
378 GASTRIC DISORDER 25
379 INJECTION SITE BRUISING 25
380 KOUNIS SYNDROME 25
381 PHYSICAL DISABILITY 25
382 SECRETION DISCHARGE 25
383 DEPRESSED MOOD 24
384 INTERNATIONAL NORMALISED RATIO FLUCTUATION 24
385 PRODUCT COMPLAINT 24
386 BLOODY DISCHARGE 23
387 CYSTITIS 23
388 DISTURBANCE IN ATTENTION 23
389 DYSGEUSIA 23
390 HEART RATE INCREASED 23
391 IRON DEFICIENCY 23
392 MENTAL DISORDER 23
393 THERAPEUTIC RESPONSE SHORTENED 23
394 TOXICITY TO VARIOUS AGENTS 23
395 DERMATITIS ALLERGIC 22
396 DRUG DOSE OMISSION 22
397 MOUTH ULCERATION 22
398 RETCHING 22
399 ANAPHYLACTIC SHOCK 21
400 GASTROENTERITIS VIRAL 21
401 GASTROINTESTINAL HAEMORRHAGE 21
402 HEART RATE DECREASED 21
403 LIMB DISCOMFORT 21
404 MUSCULOSKELETAL DISCOMFORT 21
405 PANIC ATTACK 21
406 ROTATOR CUFF REPAIR 21
407 SPEECH DISORDER 21
408 SUSPECTED OFF LABEL USE 21
409 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20
410 LIMB INJURY 20
411 PHOTOSENSITIVITY REACTION 20
412 BLOOD GLUCOSE INCREASED 19
413 HAEMORRHAGE 19
414 HOT FLUSH 19
415 MULTIPLE SCLEROSIS RELAPSE 19
416 MYOCARDIAL INFARCTION 19
417 NEURALGIA 19
418 TUBERCULOSIS 19
419 BLOOD PRESSURE SYSTOLIC INCREASED 18
420 COGNITIVE DISORDER 18
421 CONCUSSION 18
422 DECREASED IMMUNE RESPONSIVENESS 18
423 DRUG ABUSE 18
424 DYSARTHRIA 18
425 GASTRITIS 18
426 HAEMATEMESIS 18
427 LYMPHADENOPATHY 18
428 PRODUCT PRESCRIBING ERROR 18
429 SKIN LESION 18
430 BONE PAIN 17
431 BRAIN INJURY 17
432 CONJUNCTIVITIS 17
433 DYSPHONIA 17
434 EMBOLIA CUTIS MEDICAMENTOSA 17
435 EPISTAXIS 17
436 FOOT FRACTURE 17
437 HALLUCINATION 17
438 NAIL OPERATION 17
439 NEOPLASM MALIGNANT 17
440 OCULAR HYPERAEMIA 17
441 PRODUCT DOSE OMISSION 17
442 SKIN DISCOLOURATION 17
443 SWOLLEN TONGUE 17
444 THERAPY CESSATION 17
445 WITHDRAWAL SYNDROME 17
446 ANHEDONIA 16
447 BLOOD PRESSURE FLUCTUATION 16
448 FUNGAL INFECTION 16
449 HEAD INJURY 16
450 INJECTION SITE SWELLING 16
451 LETHARGY 16
452 POLLAKIURIA 16
453 POOR QUALITY SLEEP 16
454 POOR VENOUS ACCESS 16
455 RENAL DISORDER 16
456 SKIN ULCER 16
457 BLINDNESS 15
458 INTERVERTEBRAL DISC PROTRUSION 15
459 MUSCULOSKELETAL CHEST PAIN 15
460 OBSTRUCTIVE AIRWAYS DISORDER 15
461 PRURITUS GENERALISED 15
462 RESTLESS LEGS SYNDROME 15
463 RESTLESSNESS 15
464 SKIN EXFOLIATION 15
465 VIRAL INFECTION 15
466 ANGIOEDEMA 14
467 ANKLE FRACTURE 14
468 BEDRIDDEN 14
469 BLOOD CREATININE INCREASED 14
470 BONE DISORDER 14
471 BRONCHOSPASM 14
472 COLITIS 14
473 DIPLOPIA 14
474 END STAGE RENAL DISEASE 14
475 EYE IRRITATION 14
476 FLATULENCE 14
477 HAEMATOCHEZIA 14
478 INCREASED TENDENCY TO BRUISE 14
479 INJECTION SITE PRURITUS 14
480 INTENTIONAL OVERDOSE 14
481 IRRITABILITY 14
482 JOINT INJURY 14
483 METABOLIC ACIDOSIS 14
484 NERVOUSNESS 14
485 PALLOR 14
486 PRODUCT USED FOR UNKNOWN INDICATION 14
487 QUALITY OF LIFE DECREASED 14
488 SNEEZING 14
489 SPINAL DISORDER 14
490 SUICIDE ATTEMPT 14
491 TINNITUS 14
492 ACQUIRED PORPHYRIA 13
493 BLOOD POTASSIUM DECREASED 13
494 BLOOD URINE PRESENT 13
495 BREAST CANCER 13
496 CARDIAC ARREST 13
497 CARDIAC FAILURE 13
498 CARDIO-RESPIRATORY ARREST 13
499 CRYING 13
500 EYE SWELLING 13
501 HEPATIC STEATOSIS 13
502 MALIGNANT NEOPLASM PROGRESSION 13
503 MENTAL IMPAIRMENT 13
504 MILIARIA 13
505 OVERWEIGHT 13
506 SACROILIITIS 13
507 SEASONAL ALLERGY 13
508 SINUS DISORDER 13
509 SKIN DISORDER 13
510 SKIN INFECTION 13
511 SKIN REACTION 13
512 STEVENS-JOHNSON SYNDROME 13
513 TENDER JOINT COUNT 13
514 ALANINE AMINOTRANSFERASE INCREASED 12
515 ATRIAL FIBRILLATION 12
516 CATARACT 12
517 DRUG DEPENDENCE 12
518 ECZEMA 12
519 EOSINOPHILIA 12
520 EXCESSIVE EYE BLINKING 12
521 FEELING JITTERY 12
522 HANGOVER 12
523 IMPAIRED GASTRIC EMPTYING 12
524 INTERSTITIAL LUNG DISEASE 12
525 LOCALISED INFECTION 12
526 MULTIPLE SCLEROSIS 12
527 ORAL CANDIDIASIS 12
528 ORAL HERPES 12
529 PRODUCT ADMINISTRATION INTERRUPTED 12
530 RENAL FAILURE ACUTE 12
531 RHABDOMYOLYSIS 12
532 SINUS CONGESTION 12
533 SPINAL PAIN 12
534 TEMPERATURE INTOLERANCE 12
535 APPLICATION SITE ERYTHEMA 11
536 BLOOD PRESSURE DECREASED 11
537 BONE DENSITY DECREASED 11
538 CARPAL TUNNEL SYNDROME 11
539 CHOLELITHIASIS 11
540 DRUG EFFECT INCOMPLETE 11
541 DYSPNOEA EXERTIONAL 11
542 EJECTION FRACTION DECREASED 11
543 FAECES DISCOLOURED 11
544 HEAD DISCOMFORT 11
545 INJECTION SITE URTICARIA 11
546 INTENTIONAL DOSE OMISSION 11
547 INTERVERTEBRAL DISC DEGENERATION 11
548 NEUTROPENIA 11
549 PANCREATIC DISORDER 11
550 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11
551 PRODUCT CONTAMINATION 11
552 PRODUCT CONTAMINATION PHYSICAL 11
553 PRODUCT ODOUR ABNORMAL 11
554 RED BLOOD CELL COUNT DECREASED 11
555 RENAL INJURY 11
556 RESPIRATORY TRACT CONGESTION 11
557 SYNOVIAL CYST 11
558 THERAPY INTERRUPTED 11
559 ULCER 11
560 APHONIA 10
561 ASPARTATE AMINOTRANSFERASE INCREASED 10
562 ATELECTASIS 10
563 BRONCHIAL HYPERREACTIVITY 10
564 CARDIOMYOPATHY 10
565 DERMATITIS ATOPIC 10
566 DEVICE MALFUNCTION 10
567 DISORIENTATION 10
568 DYSURIA 10
569 HERNIA 10
570 HYPERSOMNIA 10
571 HYPOACUSIS 10
572 JOINT ARTHROPLASTY 10
573 LIGAMENT SPRAIN 10
574 MATERNAL EXPOSURE BEFORE PREGNANCY 10
575 MOOD SWINGS 10
576 NODULE 10
577 PANCYTOPENIA 10
578 PLATELET COUNT DECREASED 10
579 PNEUMONITIS 10
580 PRODUCT PHYSICAL ISSUE 10
581 PULMONARY OEDEMA 10
582 RASH MACULAR 10
583 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 10
584 SPONDYLOARTHROPATHY 10
585 UPPER-AIRWAY COUGH SYNDROME 10
586 ABASIA 9
587 APPLICATION SITE BURN 9
588 APPLICATION SITE PAIN 9
589 BASAL CELL CARCINOMA 9
590 BIPOLAR DISORDER 9
591 BODY TEMPERATURE DECREASED 9
592 CREPITATIONS 9
593 CYST 9
594 DERMATITIS EXFOLIATIVE 9
595 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9
596 DRUG RESISTANCE 9
597 ERYTHEMA MULTIFORME 9
598 EXPOSURE VIA SKIN CONTACT 9
599 HEPATOTOXICITY 9
600 HYPERKALAEMIA 9
601 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9
602 INITIAL INSOMNIA 9
603 INJECTION SITE MASS 9
604 KIDNEY INFECTION 9
605 LIP SWELLING 9
606 MELAENA 9
607 MENOPAUSE 9
608 NERVE INJURY 9
609 PARAESTHESIA ORAL 9
610 PHARYNGEAL SWELLING 9
611 PHOTOPSIA 9
612 POST PROCEDURAL INFECTION 9
613 PRODUCT COLOUR ISSUE 9
614 RENAL CYST 9
615 RESPIRATORY DISTRESS 9
616 SYNOVIAL DISORDER 9
617 THROAT TIGHTNESS 9
618 TOXIC EPIDERMAL NECROLYSIS 9
619 UVEITIS 9
620 AGITATION 8
621 APPLICATION SITE DISCOLOURATION 8
622 ARTHROPOD BITE 8
623 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 8
624 ATTENTION DEFICIT HYPERACTIVITY DISORDER 8
625 BLOOD IRON DECREASED 8
626 BLOOD PRESSURE ABNORMAL 8
627 BLOOD PRESSURE DIASTOLIC DECREASED 8
628 BREATH SOUNDS ABNORMAL 8
629 CATAPLEXY 8
630 COMA 8
631 CYANOSIS 8
632 DYSKINESIA 8
633 EXPIRED PRODUCT ADMINISTERED 8
634 EYE PRURITUS 8
635 FLANK PAIN 8
636 FRACTURE 8
637 HAEMANGIOMA 8
638 HAEMOPTYSIS 8
639 HYPERGLYCAEMIA 8
640 HYPOCALCAEMIA 8
641 HYPOGLYCAEMIA 8
642 HYPOTHYROIDISM 8
643 INFUSION SITE EXTRAVASATION 8
644 INFUSION SITE SWELLING 8
645 INTERNAL HAEMORRHAGE 8
646 ISCHAEMIC CARDIOMYOPATHY 8
647 LARGE INTESTINE PERFORATION 8
648 LIVER FUNCTION TEST ABNORMAL 8
649 NEOPLASM PROGRESSION 8
650 NERVOUS SYSTEM DISORDER 8
651 ONYCHOCLASIS 8
652 OSTEOMYELITIS 8
653 OSTEOPENIA 8
654 PLEURAL EFFUSION 8
655 PROCEDURAL PAIN 8
656 PULMONARY FUNCTION TEST ABNORMAL 8
657 RASH PAPULAR 8
658 RESPIRATORY ARREST 8
659 RHINITIS ALLERGIC 8
660 RIB FRACTURE 8
661 SEPTIC SHOCK 8
662 SKIN IRRITATION 8
663 SPINAL OPERATION 8
664 TENSION HEADACHE 8
665 THROMBOTIC THROMBOCYTOPENIC PURPURA 8
666 TOOTH ABSCESS 8
667 TRANSIENT ISCHAEMIC ATTACK 8
668 TUBULOINTERSTITIAL NEPHRITIS 8
669 ABORTION SPONTANEOUS 7
670 ACNE 7
671 ACTIVITIES OF DAILY LIVING IMPAIRED 7
672 AGEUSIA 7
673 ALLERGY TO CHEMICALS 7
674 ANGER 7
675 APHASIA 7
676 APPLICATION SITE IRRITATION 7
677 APPLICATION SITE PRURITUS 7
678 ASPARTATE AMINOTRANSFERASE ABNORMAL 7
679 BLOOD CREATININE DECREASED 7
680 BLOOD PRESSURE DIASTOLIC INCREASED 7
681 BODY HEIGHT DECREASED 7
682 BONE MARROW OEDEMA 7
683 BRAIN FOG 7
684 CHOLECYSTECTOMY 7
685 CHROMATURIA 7
686 CUSHINGOID 7
687 DIVERTICULITIS 7
688 DRUG EFFECT LESS THAN EXPECTED 7
689 DRUG WITHDRAWAL SYNDROME 7
690 ECONOMIC PROBLEM 7
691 ENTHESOPATHY 7
692 FEBRILE NEUTROPENIA 7
693 FURUNCLE 7
694 HUNGER 7
695 HYSTERECTOMY 7
696 INJECTION SITE HAEMORRHAGE 7
697 LYMPHOCYTE COUNT DECREASED 7
698 LYMPHOMA 7
699 MASS 7
700 NASAL ULCER 7
701 NEPHROPATHY 7
702 PANCREATITIS ACUTE 7
703 PHARYNGITIS STREPTOCOCCAL 7
704 PLEURITIC PAIN 7
705 PREGNANCY AFTER POST COITAL CONTRACEPTION 7
706 PRESYNCOPE 7
707 RESPIRATORY FAILURE 7
708 RHEUMATOID NODULE 7
709 RHINITIS 7
710 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7
711 SNORING 7
712 SPINAL OSTEOARTHRITIS 7
713 STAPHYLOCOCCAL SEPSIS 7
714 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 7
715 TENOSYNOVITIS 7
716 TOOTH DISORDER 7
717 TRICUSPID VALVE INCOMPETENCE 7
718 URINARY RETENTION 7
719 VAGINAL HAEMORRHAGE 7
720 VAGINAL INFECTION 7
721 VITAMIN D DECREASED 7
722 ABNORMAL DREAMS 6
723 ACCIDENT 6
724 AFFECT LABILITY 6
725 ANTINUCLEAR ANTIBODY POSITIVE 6
726 ANTIPHOSPHOLIPID ANTIBODIES 6
727 ASCITES 6
728 BLINDNESS UNILATERAL 6
729 BLOOD ALBUMIN DECREASED 6
730 BLOOD CREATINE PHOSPHOKINASE INCREASED 6
731 BLOOD GLUCOSE DECREASED 6
732 CLOSTRIDIUM DIFFICILE INFECTION 6
733 CORONARY ARTERY DISEASE 6
734 DACTYLITIS 6
735 DERMATITIS BULLOUS 6
736 DRUG ADMINISTRATION ERROR 6
737 DUCTUS ARTERIOSUS STENOSIS FOETAL 6
738 FEMUR FRACTURE 6
739 GALLBLADDER DISORDER 6
740 GASTROENTERITIS 6
741 GLAUCOMA 6
742 GLUCOSE TOLERANCE IMPAIRED 6
743 HAEMATOMA 6
744 HAIR TEXTURE ABNORMAL 6
745 HEPATIC ENZYME ABNORMAL 6
746 HIATUS HERNIA 6
747 HIP FRACTURE 6
748 HYPOAESTHESIA ORAL 6
749 HYPOMAGNESAEMIA 6
750 HYPOXIA 6
751 INFLAMMATORY PAIN 6
752 INTESTINAL DIAPHRAGM DISEASE 6
753 INTESTINAL OBSTRUCTION 6
754 LACRIMATION INCREASED 6
755 MICTURITION URGENCY 6
756 MIDDLE INSOMNIA 6
757 MOOD ALTERED 6
758 MULTIPLE FRACTURES 6
759 MUSCLE TIGHTNESS 6
760 NEEDLE ISSUE 6
761 NERVE COMPRESSION 6
762 NON-ALCOHOLIC STEATOHEPATITIS 6
763 ORAL PAIN 6
764 OVARIAN CYST 6
765 PAIN OF SKIN 6
766 PERIPHERAL COLDNESS 6
767 PNEUMOTHORAX 6
768 POST PROCEDURAL COMPLICATION 6
769 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6
770 PRODUCT ADMINISTRATION ERROR 6
771 PRODUCT AVAILABILITY ISSUE 6
772 PRODUCT DISTRIBUTION ISSUE 6
773 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6
774 PRODUCT PREPARATION ERROR 6
775 PRODUCT PRESCRIBING ISSUE 6
776 RASH GENERALISED 6
777 RENAL TUBULAR NECROSIS 6
778 RUBBER SENSITIVITY 6
779 SCLERITIS 6
780 SICCA SYNDROME 6
781 SKIN LACERATION 6
782 SOMNAMBULISM 6
783 SUPRAVENTRICULAR TACHYCARDIA 6
784 TENOSYNOVITIS STENOSANS 6
785 TOOTH LOSS 6
786 TOOTHACHE 6
787 ULCERATIVE KERATITIS 6
788 URINARY INCONTINENCE 6
789 VITAMIN D DEFICIENCY 6
790 VULVOVAGINAL CANDIDIASIS 6
791 WRIST FRACTURE 6
792 ABDOMINAL PAIN LOWER 5
793 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5
794 ACUTE MYOCARDIAL INFARCTION 5
795 ANGINA PECTORIS 5
796 APHTHOUS ULCER 5
797 APPLICATION SITE DISCOMFORT 5
798 APPLICATION SITE PARAESTHESIA 5
799 AURA 5
800 AUTOIMMUNE THYROIDITIS 5
801 BLOOD SODIUM DECREASED 5
802 BLOOD UREA INCREASED 5
803 BRUXISM 5
804 CARDIAC FAILURE CONGESTIVE 5
805 CONVULSION 5
806 COORDINATION ABNORMAL 5
807 DEMENTIA 5
808 DEPRESSED LEVEL OF CONSCIOUSNESS 5
809 DEVICE ISSUE 5
810 DRUG DOSE OMISSION BY DEVICE 5
811 DYSPHEMIA 5
812 EMOTIONAL DISORDER 5
813 EXERCISE TOLERANCE DECREASED 5
814 EYE HAEMORRHAGE 5
815 FACIAL PARALYSIS 5
816 FEAR 5
817 FEELING DRUNK 5
818 GALLBLADDER OPERATION 5
819 GASTRITIS EROSIVE 5
820 GENERALISED OEDEMA 5
821 HAND FRACTURE 5
822 HEPATOCELLULAR INJURY 5
823 HYPOKINESIA 5
824 IMPAIRED DRIVING ABILITY 5
825 IMPAIRED QUALITY OF LIFE 5
826 INFUSION SITE PAIN 5
827 INFUSION SITE PRURITUS 5
828 INJECTION SITE WARMTH 5
829 JAUNDICE 5
830 LACTIC ACIDOSIS 5
831 LOWER GASTROINTESTINAL HAEMORRHAGE 5
832 LYMPHOCYTOSIS 5
833 MASTOIDITIS 5
834 MENORRHAGIA 5
835 METASTASES TO LYMPH NODES 5
836 MULTI-ORGAN FAILURE 5
837 MUSCLE CONTRACTURE 5
838 MUSCLE TWITCHING 5
839 NEUROLOGICAL SYMPTOM 5
840 NEUTROPHIL COUNT INCREASED 5
841 OSTEONECROSIS 5
842 PHARYNGEAL OEDEMA 5
843 PLANTAR FASCIITIS 5
844 POLYCHONDRITIS 5
845 POST-TRAUMATIC NECK SYNDROME 5
846 PRODUCT DIFFICULT TO SWALLOW 5
847 PRODUCT SUBSTITUTION ISSUE 5
848 PROTEIN TOTAL INCREASED 5
849 PSYCHOLOGICAL TRAUMA 5
850 PULMONARY HYPERTENSION 5
851 RESPIRATORY RATE INCREASED 5
852 ROTATOR CUFF SYNDROME 5
853 SCOLIOSIS 5
854 SHOCK 5
855 SKIN BURNING SENSATION 5
856 SKIN FISSURES 5
857 SKIN HAEMORRHAGE 5
858 SLUGGISHNESS 5
859 SPINAL COLUMN STENOSIS 5
860 SPUTUM DISCOLOURED 5
861 SYMPTOM RECURRENCE 5
862 TACHYPHRENIA 5
863 TENDONITIS 5
864 TERMINAL INSOMNIA 5
865 THERMAL BURN 5
866 THINKING ABNORMAL 5
867 THYROID DISORDER 5
868 TONGUE DISORDER 5
869 UNRESPONSIVE TO STIMULI 5
870 UPPER GASTROINTESTINAL HAEMORRHAGE 5
871 VAGINAL DISCHARGE 5
872 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5
873 ACUTE RESPIRATORY FAILURE 4
874 AGGRESSION 4
875 ANEURYSM RUPTURED 4
876 ANGIOPATHY 4
877 APPENDICITIS 4
878 APPLICATION SITE EXFOLIATION 4
879 APPLICATION SITE PAPULES 4
880 APPLICATION SITE URTICARIA 4
881 ARRHYTHMIA 4
882 BLOOD CALCIUM DECREASED 4
883 BLOOD CALCIUM INCREASED 4
884 BLOOD CHOLESTEROL 4
885 BLOOD COUNT ABNORMAL 4
886 BODY TEMPERATURE FLUCTUATION 4
887 BRADYCARDIA 4
888 CERVICAL RADICULOPATHY 4
889 CLOSTRIDIUM DIFFICILE COLITIS 4
890 COLD SWEAT 4
891 CONJUNCTIVAL HYPERAEMIA 4
892 DEREALISATION 4
893 DERMATITIS CONTACT 4
894 DIAPHRAGMATIC HERNIA 4
895 DIARRHOEA HAEMORRHAGIC 4
896 EAR DISCOMFORT 4
897 ENCEPHALOPATHY 4
898 ENDOMETRIOSIS 4
899 ENDOTRACHEAL INTUBATION 4
900 ESCHERICHIA INFECTION 4
901 EUPHORIC MOOD 4
902 EXTRA DOSE ADMINISTERED 4
903 EYELID PTOSIS 4
904 FACE OEDEMA 4
905 FACIAL PAIN 4
906 FEAR OF INJECTION 4
907 FOOD AVERSION 4
908 GASTRIC HAEMORRHAGE 4
909 GASTROINTESTINAL ULCER 4
910 GENERALISED ERYTHEMA 4
911 GENERALISED TONIC-CLONIC SEIZURE 4
912 GLOMERULONEPHRITIS MINIMAL LESION 4
913 GOUT 4
914 HAEMORRHAGIC DIATHESIS 4
915 HALLUCINATIONS, MIXED 4
916 HEART RATE ABNORMAL 4
917 HEPATIC FAILURE 4
918 HEPATITIS ACUTE 4
919 HEREDITARY ANGIOEDEMA 4
920 HYDROCEPHALUS 4
921 HYPERLIPIDAEMIA 4
922 HYPERPARATHYROIDISM SECONDARY 4
923 HYPERVOLAEMIA 4
924 IMMUNE SYSTEM DISORDER 4
925 IMPAIRED SELF-CARE 4
926 INCOHERENT 4
927 INCORRECT DRUG ADMINISTRATION RATE 4
928 INFECTED SKIN ULCER 4
929 INFUSION SITE DISCHARGE 4
930 INFUSION SITE ERYTHEMA 4
931 INJECTION SITE DISCOLOURATION 4
932 INJECTION SITE IRRITATION 4
933 INJECTION SITE RASH 4
934 INJECTION SITE SCAR 4
935 INTERNATIONAL NORMALISED RATIO INCREASED 4
936 INTERSTITIAL GRANULOMATOUS DERMATITIS 4
937 IRITIS 4
938 IRON DEFICIENCY ANAEMIA 4
939 KNEE OPERATION 4
940 LEUKOCYTOSIS 4
941 LYMPHOEDEMA 4
942 MAJOR DEPRESSION 4
943 MENTAL STATUS CHANGES 4
944 MULTIPLE ALLERGIES 4
945 MYASTHENIA GRAVIS 4
946 MYDRIASIS 4
947 NASAL DISCOMFORT 4
948 NECK INJURY 4
949 NEPHROGENIC ANAEMIA 4
950 NOCTURIA 4
951 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4
952 OTITIS MEDIA 4
953 PARANOIA 4
954 PAROSMIA 4
955 PELVIC PAIN 4
956 PEPTIC ULCER 4
957 PETECHIAE 4
958 PHONOPHOBIA 4
959 PIGMENTATION DISORDER 4
960 PLASMA CELL MYELOMA 4
961 PNEUMONIA ASPIRATION 4
962 POST PROCEDURAL HAEMORRHAGE 4
963 PRODUCT ADHESION ISSUE 4
964 PRODUCT DOSE OMISSION IN ERROR 4
965 PRODUCT FORMULATION ISSUE 4
966 PRODUCT LABEL ISSUE 4
967 PRODUCT PHYSICAL CONSISTENCY ISSUE 4
968 PRODUCT STORAGE ERROR 4
969 PROSTATE CANCER 4
970 PULMONARY MASS 4
971 PYELONEPHRITIS 4
972 RADICULOPATHY 4
973 RASH MACULO-PAPULAR 4
974 RED CELL DISTRIBUTION WIDTH INCREASED 4
975 ROSACEA 4
976 SEROTONIN SYNDROME 4
977 SHOULDER OPERATION 4
978 SJOGREN^S SYNDROME 4
979 SKIN ABRASION 4
980 SOFT TISSUE INJURY 4
981 SPINAL DEFORMITY 4
982 SUBARACHNOID HAEMORRHAGE 4
983 TENDON DISORDER 4
984 TENSION 4
985 THERAPY PARTIAL RESPONDER 4
986 THYROID CANCER 4
987 TOOTH EXTRACTION 4
988 TOOTH INFECTION 4
989 TRANSAMINASES INCREASED 4
990 TRIGEMINAL NEURALGIA 4
991 UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE 4
992 UPPER LIMB FRACTURE 4
993 UTERINE LEIOMYOMA 4
994 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4
995 ABNORMAL BEHAVIOUR 3
996 ACUTE HEPATIC FAILURE 3
997 AGRANULOCYTOSIS 3
998 AKATHISIA 3
999 ALTERED STATE OF CONSCIOUSNESS 3